
The medical device industry may be robust overall but underlying this growth is a range of mature products supported by fewer introductions that account for most of the industry's current success. Many of these newer technology advances integrate drugs, information and services with established technologies to produce more effective products for existing patient conditions. For medical device companies to succeed in this environment, they must build and continuously maintain competitive advantage by constantly reinforcing their value proposition to the appropriately targeted medical, patient, and payer communities.
Putnam assists medical device companies in a variety of strategic issues. We provide a comprehensive understanding of the value impact of new products, markets and technologies. We help assess markets, analyze competitors, and forecast revenues to develop successful growth strategies. We also define the position of potential investments, partnerships and acquisitions and present a clear rationale for which products to outlicense and which to retain.